title: Dermatomyositis and malignant melanoma: a rare association that worsens prognosis?
authors.affiliation: Dermatology Department, Alto Guadalquivir Hospital. Andujar, Jaén, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Fernández-Crehuet
authors.forename: A
authors.initials: A
authors.lastname: Pérez-Gil
authors.forename: A
authors.initials: A
authors.lastname: Herrera-Saval
authors.forename: C
authors.initials: C
authors.lastname: Cantalejo-Rodríguez
authors.forename: J J
authors.initials: JJ
authors.lastname: Ríos-Martín
authors.forename: F M
authors.initials: FM
authors.lastname: Camacho-Martínez
mesh_terms: D001859:Bone Neoplasms / Q000556:secondary*; D003882:Dermatomyositis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy / Q000473:pathology*; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D011379:Prognosis; D011994:Recombinant Proteins / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology*; D016896:Treatment Outcome
chemical_list: D005938:Glucocorticoids; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D008775:Methylprednisolone